About the API
Pregabalin is used to manage neuropathic pain (pain associated with nerve damage) and postherpetic neuralgia (a painful complication of shingles), and as adjunctive therapy for adult patients with partial onset seizures (epileptic fits starting in one specific part of the brain).
In addition, it is used to treat fibromyalgia (a disorder characterized by widespread musculoskeletal pain) and treatment of generalized anxiety disorder, according to country. Administered as an oral tablet or solution, pregabalin is the first FDA-approved drug for fibromyalgia. In the US, its use for neuropathic pain is limited to peripheral pain associated with diabetes.
Pregabalin is being studied for the alleviation of pain in a wide range of conditions. It is a Schedule V controlled substance according to the US Controlled Substances Act (i.e., lowest potential for abuse).
Pregabalin was approved in the US and the EU in 2004. In 2007, the FDA approved its use for fibromyalgia. It is prepared through multi-step chemical synthesis.